Pediatric dosing of antimicrobials: Difference between revisions

From IDWiki
(: added glycopeptides)
mNo edit summary
 
(19 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
=== Penicillins ===
 
=== Penicillins ===
   
{| class="wikitable"
+
{| class="wikitable" style="width:100%"
 
! Drug
 
! Drug
 
! Indication
 
! Indication
! Age
+
! Age and weight
! Weight
+
! Dose
! Usual dose
 
 
|-
 
|-
 
| rowspan=2 | [[Penicillin]] G IV/IM
 
| rowspan=2 | [[Penicillin]] G IV/IM
 
| moderate to severe infections
 
| moderate to severe infections
  +
|
| colspan=2 |
 
 
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
 
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
 
|-
 
|-
 
| meningitis
 
| meningitis
  +
|
| colspan=2 |
 
 
| 400,000 U/kg/day split q4h (max 24 MU/day)
 
| 400,000 U/kg/day split q4h (max 24 MU/day)
 
|-
 
|-
 
| rowspan=6 | [[Penicillin]] VK PO
 
| rowspan=6 | [[Penicillin]] VK PO
 
| mild to moderate infections
 
| mild to moderate infections
  +
|
| colspan=2 |
 
 
| 25-50 mg/kg/day split q8-12h
 
| 25-50 mg/kg/day split q8-12h
 
|-
 
|-
 
| rowspan=2 | rheumatic fever (treatment)
 
| rowspan=2 | rheumatic fever (treatment)
| rowspan=2 |
 
 
| ≤ 27 kg
 
| ≤ 27 kg
 
| 300 mg PO bid x10 days
 
| 300 mg PO bid x10 days
Line 34: Line 32:
 
| rheumatic fever (prophylaxis)
 
| rheumatic fever (prophylaxis)
 
| > 5 years
 
| > 5 years
|
 
 
| 300 mg PO bid
 
| 300 mg PO bid
 
|-
 
|-
 
| rowspan=2 | asplenia (prophylaxis)
 
| rowspan=2 | asplenia (prophylaxis)
| 6 months to 5 years
+
| 6 months to 5 years
| rowspan=2 |
 
 
| 150 mg PO bid
 
| 150 mg PO bid
 
|-
 
|-
Line 47: Line 43:
 
| [[Cloxacillin]] IV
 
| [[Cloxacillin]] IV
 
| methicillin-susceptible [[Staphylococcus aureus]]
 
| methicillin-susceptible [[Staphylococcus aureus]]
  +
|
| colspan=2 |
 
 
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
 
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
 
|-
 
|-
 
| [[Cloxacillin]] PO
 
| [[Cloxacillin]] PO
| colspan=3 |
+
| colspan=2 |
 
| use [[cephalexin]] instead
 
| use [[cephalexin]] instead
 
|-
 
|-
Line 57: Line 53:
 
| rowspan=2 | usual dose
 
| rowspan=2 | usual dose
 
| neonates
 
| neonates
|
 
 
| 100-200 mg/kg/day split q6-8h
 
| 100-200 mg/kg/day split q6-8h
 
|-
 
|-
 
| infants and children
 
| infants and children
|
 
 
| 100-200 mg/kg/day split q6h (max 2 g/dose)
 
| 100-200 mg/kg/day split q6h (max 2 g/dose)
 
|-
 
|-
 
| rowspan=2 | meningitis
 
| rowspan=2 | meningitis
 
| neonates
 
| neonates
|
 
 
| 300 mg/kg/day split q6-8h
 
| 300 mg/kg/day split q6-8h
 
|-
 
|-
 
| infants and children
 
| infants and children
|
 
 
| 300-400 mg/kg/day split q4-6h (max 2 g/dose)
 
| 300-400 mg/kg/day split q4-6h (max 2 g/dose)
 
|-
 
|-
 
| rowspan=3 | [[Amoxicillin]] PO
 
| rowspan=3 | [[Amoxicillin]] PO
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 40-50 mg/kg/day split q8h
 
| 40-50 mg/kg/day split q8h
 
|-
 
|-
 
| [[Streptococcus pneumoniae]]
 
| [[Streptococcus pneumoniae]]
  +
|
| colspan=2 |
 
 
| 80-90 mg/kg/day split q8h
 
| 80-90 mg/kg/day split q8h
 
|-
 
|-
 
| [[Group A Streptococcus]] pharyngitis
 
| [[Group A Streptococcus]] pharyngitis
  +
|
| colspan=2 |
 
 
| 50 mg/kg once daily x10 days (max 1 g/dose)
 
| 50 mg/kg once daily x10 days (max 1 g/dose)
 
|-
 
|-
 
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO
 
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
 
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
 
|-
 
|-
 
| [[Streptococcus pneumoniae]]
 
| [[Streptococcus pneumoniae]]
  +
|
| colspan=2 |
 
 
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
 
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
 
|-
 
|-
 
| rowspan=2 | [[Piperacillin-tazobactam]] IV
 
| rowspan=2 | [[Piperacillin-tazobactam]] IV
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 240-300 mg/kg/day (pip component) split q6-8h
 
| 240-300 mg/kg/day (pip component) split q6-8h
 
|-
 
|-
 
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]]
 
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]]
  +
|
| colspan=2 |
 
 
| 400 mg/kg/day split q6h
 
| 400 mg/kg/day split q6h
 
|}
 
|}
   
 
=== Cephalosporins ===
 
=== Cephalosporins ===
{| class="wikitable"
+
{| class="wikitable" style="width:100%"
 
! Drug
 
! Drug
 
! Indication
 
! Indication
! Age
+
! Age and weight
! Weight
+
! Dose
! Usual dose
 
 
|-
 
|-
 
! colspan=5 | First generation
 
! colspan=5 | First generation
Line 117: Line 108:
 
| [[Cefazolin]] IV/IM
 
| [[Cefazolin]] IV/IM
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
 
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
 
|-
 
|-
 
| rowspan=2 | [[Cephalexin]] PO
 
| rowspan=2 | [[Cephalexin]] PO
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 25-100 mg/kg/day split qid
 
| 25-100 mg/kg/day split qid
 
|-
 
|-
 
| [[osteomyelitis]] (oral step-down)
 
| [[osteomyelitis]] (oral step-down)
  +
|
| colspan=2 |
 
 
| 100-150 mg/kg/day split qid
 
| 100-150 mg/kg/day split qid
 
|-
 
|-
Line 133: Line 124:
 
| [[Cefuroxime]] IV/IM
 
| [[Cefuroxime]] IV/IM
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 100-150 mg/kg/day split q8h (max 2 g/dose)
 
| 100-150 mg/kg/day split q8h (max 2 g/dose)
 
|-
 
|-
 
| [[Cefuroxime]] azetil PO
 
| [[Cefuroxime]] azetil PO
| colspan=3 |
+
| colspan=2 |
 
| poor bioavailability; not recommended
 
| poor bioavailability; not recommended
 
|-
 
|-
 
| [[Cefprozil]] PO
 
| [[Cefprozil]] PO
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 15-30 mg/kg/day split bid (max 1 g/day)
 
| 15-30 mg/kg/day split bid (max 1 g/day)
 
|-
 
|-
Line 150: Line 141:
 
| rowspan=3 | usual dose
 
| rowspan=3 | usual dose
 
| 0-7 days
 
| 0-7 days
|
 
 
| 50 mg/kg/dose q8h
 
| 50 mg/kg/dose q8h
 
|-
 
|-
 
| >7 days
 
| >7 days
|
 
 
| 50 mg/kg/dose q8h
 
| 50 mg/kg/dose q8h
 
|-
 
|-
 
| infants and children
 
| infants and children
|
 
 
| 100-200 mg/kg/day split q6-8h (max 6 g/day)
 
| 100-200 mg/kg/day split q6-8h (max 6 g/day)
 
|-
 
|-
 
| rowspan=3 | [[meningitis]]
 
| rowspan=3 | [[meningitis]]
 
| 0-7 days
 
| 0-7 days
|
 
 
| 50 mg/kg/dose q8h
 
| 50 mg/kg/dose q8h
 
|-
 
|-
 
| >7 days
 
| >7 days
|
 
 
| 50 mg/kg/dose q6h
 
| 50 mg/kg/dose q6h
 
|-
 
|-
 
| infants and children
 
| infants and children
|
 
 
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
 
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
 
|-
 
|-
Line 177: Line 162:
 
| usual dose
 
| usual dose
 
| >1 month
 
| >1 month
|
 
 
| 50-75 mg/kg q24h (max 2 g/day)
 
| 50-75 mg/kg q24h (max 2 g/day)
 
|-
 
|-
 
| [[meningitis]]
 
| [[meningitis]]
 
| >1 month
 
| >1 month
|
 
 
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
 
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
 
|-
 
|-
 
| rowspan=2 | [[gonorrhea]]
 
| rowspan=2 | [[gonorrhea]]
 
| ≥9 years
 
| ≥9 years
|
 
 
| 250 mg IM once
 
| 250 mg IM once
 
|-
 
|-
 
| <9 years
 
| <9 years
|
 
 
| 50 mg/kg IM once (max 250 mg)
 
| 50 mg/kg IM once (max 250 mg)
 
|-
 
|-
 
| rowspan=2 | [[Ceftazidime]] IM/IV
 
| rowspan=2 | [[Ceftazidime]] IM/IV
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
 
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
 
|-
 
|-
 
| [[meningitis]] or [[cystic fibrosis]]
 
| [[meningitis]] or [[cystic fibrosis]]
  +
|
| colspan=2 |
 
 
| 200 mg/kg/day split q6-8h (max 6 g/day)
 
| 200 mg/kg/day split q6-8h (max 6 g/day)
 
|-
 
|-
 
| [[Cefixime]] PO
 
| [[Cefixime]] PO
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 8 mg/kg/day split q12-24h (max 400 mg/day)
 
| 8 mg/kg/day split q12-24h (max 400 mg/day)
 
|}
 
|}
Line 211: Line 192:
 
=== Carbapenems ===
 
=== Carbapenems ===
   
{| class="wikitable"
+
{| class="wikitable" style="width:100%"
 
! Drug
 
! Drug
 
! Indication
 
! Indication
! Age
+
! Age and weight
! Weight
+
! Dose
! Usual dose
 
 
|-
 
|-
 
| rowspan=2 | [[Meropenem]]
 
| rowspan=2 | [[Meropenem]]
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 20 mg/kg/dose q8h (max 1 g/dose)
 
| 20 mg/kg/dose q8h (max 1 g/dose)
 
|-
 
|-
 
| [[meningitis]]
 
| [[meningitis]]
  +
|
| colspan=2 |
 
 
| 40 mg/kg/dose q8h (max 2 g/dose)
 
| 40 mg/kg/dose q8h (max 2 g/dose)
 
|-
 
|-
Line 230: Line 210:
 
| rowspan=2 | usual dose
 
| rowspan=2 | usual dose
 
| 3 months to 12 years
 
| 3 months to 12 years
|
 
 
| 15 mg/kg/dose q12h (max 500 mg/dose)
 
| 15 mg/kg/dose q12h (max 500 mg/dose)
 
|-
 
|-
 
| ≥13 years
 
| ≥13 years
|
 
 
| 1 g daily
 
| 1 g daily
 
|}
 
|}
Line 240: Line 218:
 
=== Glycopeptides ===
 
=== Glycopeptides ===
   
{| class="wikitable"
+
{| class="wikitable" style="width:100%"
 
! Drug
 
! Drug
 
! Indication
 
! Indication
! Age
+
! Age and weight
! Weight
+
! Dose
! Usual dose
 
 
|-
 
|-
 
| rowspan=2 | [[Vancomycin]] IV
 
| rowspan=2 | [[Vancomycin]] IV
 
| usual dose
 
| usual dose
  +
|
| colspan=2 |
 
 
| 40-60 mg/kg/day split q6-12h (max 2+ g/day)
 
| 40-60 mg/kg/day split q6-12h (max 2+ g/day)
 
|-
 
|-
 
| [[meningitis]] or [[MRSA]]
 
| [[meningitis]] or [[MRSA]]
  +
|
| colspan=2 |
 
 
| 60 mg/kg/day split q6-8h (max 4 g/day)
 
| 60 mg/kg/day split q6-8h (max 4 g/day)
 
|-
 
|-
 
| [[Vancomycin]] PO
 
| [[Vancomycin]] PO
 
| [[Clostridium difficile]]
 
| [[Clostridium difficile]]
  +
|
| colspan=2 |
 
 
| 10 mg/kg/dose q6h (max 125 mg/dose)
 
| 10 mg/kg/dose q6h (max 125 mg/dose)
  +
|}
  +
  +
=== Macrolides ===
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
| [[Clarithromycin]] PO
  +
| usual dose
  +
|
  +
| 7.5 mg/kg/dose bid
  +
|-
  +
| rowspan=6 | [[Azithromycin]] PO/IV
  +
| usual dose
  +
|
  +
| 10 mg/kg (max 500 mg) once, then 5 mg/kg (max 250 mg) daily for 4 days
  +
|-
  +
| rowspan=2 | [[pertussis]]
  +
| <6 months
  +
| 10 mg/kg q24h for 5 days
  +
|-
  +
| ≥6 months
  +
| 10 mg/kg once (max 500 mg) then 5 mg/kg dailys (max 250 mg)
  +
|-
  +
| rowspan=2 | [[chlamydia]]
  +
| <9 years
  +
| 20 mg/kg (max 1 g) once
  +
|-
  +
| ≥9 years
  +
| 1 g once
  +
|-
  +
| chlamydial conjunctivitis
  +
| infants
  +
| 20 mg/kg once daily for 3 days
  +
|}
  +
  +
=== Aminoglycosides ===
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
| rowspan=2 | [[Tobramycin]] IV
  +
| usual dose
  +
|
  +
| 5-7 mg/kg/dose q24h
  +
|-
  +
| [[cystic fibrosis]]
  +
|
  +
| 10-12 mg/kg/dose q24h
  +
|-
  +
| [[Tobramycin]] INH
  +
| [[cystic fibrosis]]
  +
|
  +
| 80 mg bid to tid
  +
|-
  +
| rowspan=4 | [[Gentamicin]] IV
  +
| rowspan=3 | usual dose
  +
| ≤7 days
  +
| 4 mg/kg/dose q24h
  +
|-
  +
| >7 days
  +
| 5 mg/kg/dose q24h
  +
|-
  +
| infants and children
  +
| 5-7 mg/kg/dose q24h
  +
|-
  +
| synergy for Gram-positive infections
  +
| 1 mg/kg/dose q8h
  +
|}
  +
  +
* Extended-frequency dosing of aminoglycosides is preferred for all patients older than 1 month with the exception of endocarditis or extensive burns
  +
* Monitor trough levels pre-second dose, with target of <1 mg/L
  +
  +
=== Fluoroquinolones ===
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
| [[Ciprofloxacin]] IV/PO
  +
| usual dose
  +
|
  +
| 20-30 mg/kg/day split q12h (max 400 mg/dose IV or 750 mg/dose PO)
  +
|-
  +
| rowspan=2 | [[Levofloxacin]] PO/IV
  +
| rowspan=2 | usual dose
  +
| ≤5 years
  +
| 10 mg/kg q12h
  +
|-
  +
| >5 years
  +
| 10 mg/kg daily (max 750 mg/day)
  +
|}
  +
  +
=== Miscellaneous ===
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
! colspan=4 | Lincosamides
  +
|-
  +
| rowspan=2 | [[Clindamycin]] IV
  +
| usual dose
  +
|
  +
| 20-40 mg/kg/day split q6h (max 600 mg/dose)
  +
|-
  +
| [[toxic shock syndrome]] or [[necrotizing fasciitis]]
  +
|
  +
| 600-900 mg q8h
  +
|-
  +
| [[Clindamycin]] PO
  +
| usual dose
  +
|
  +
| 10-30 mg/kg/day split q6-8h
  +
|-
  +
! colspan=4 | Nitroimidazole
  +
|-
  +
| rowspan=3 | [[Metronidazole]] PO/IV
  +
| anaerobic infections
  +
|
  +
| 20-30 mg/kg/day split q8-12h (max 1500 mg/day IV or 2000 mg/day PO)
  +
|-
  +
| severe infections
  +
|
  +
| 50 mg/kg/day split q8h
  +
|-
  +
| [[C. difficile]] infection
  +
|
  +
| 30 mg/kg/day split q6-8h (max 1500 mg/day)
  +
|-
  +
! colspan=4 | Sulfonamides
  +
|-
  +
| rowspan=4 | [[Co-trimoxazole]] PO/IV
  +
| usual dose
  +
|
  +
| 8-10 mg/kg/day TMP split q12h
  +
|-
  +
| [[MRSA]]
  +
|
  +
| 8-12 mg/kg/day TMP split q12h
  +
|-
  +
| [[Pneumocystis]] pneumonia (treatment)
  +
|
  +
| 15-20 mg/kg/day TMP split q6-8h
  +
|-
  +
| [[Pneumocystis]] pneumonia (prophylaxis)
  +
|
  +
| 3-5 mg/kg/day TMP split q12h on Mon-Wed-Fri
  +
|-
  +
| [[Trimethoprim]] PO
  +
| UTI (prophylaxis)
  +
|
  +
| 2-3 mg/kg/day split q12h
  +
|-
  +
! colspan=4 | Others
  +
|-
  +
| rowspan=2 | [[Nitrofurantoin]] PO
  +
| UTI (treatment)
  +
|
  +
| 5-7 mg/kg/day split q6h (max 400 mg/day)
  +
|-
  +
| UTI (prophylaxis)
  +
|
  +
| 1-2 mg/kg/day daily
  +
|-
  +
| [[Macrobid]] PO
  +
| UTI (treatment)
  +
| >12 years
  +
| 100 mg bid
  +
|}
  +
  +
== Antifungals ==
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
| rowspan=2 | Liposomal [[amphotericin B]] IV
  +
| usual dose
  +
|
  +
| 3-5 mg/kg daily
  +
|-
  +
| severe infections
  +
|
  +
| 10 mg/kg daily
  +
|-
  +
| [[Caspofungin]] IV
  +
| usual dose
  +
|
  +
| 70 mg/m<sup>2</sup> once (max 70 mg) followed by 50 mg/m<sup>2</sup> daily (max 50 mg)
  +
|-
  +
| rowspan=3 | [[Nystatin]] PO
  +
| rowspan=3 | oral [[candidiasis]]
  +
| infants
  +
| 100,000 U swish & swallow qid
  +
|-
  +
| children
  +
| 250,000 U swish & swallow qid
  +
|-
  +
| adolescents
  +
| 500,000 U swish & swallow qid
  +
|}
  +
  +
== Antivirals ==
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age
  +
! Weight
  +
! Dose
  +
|-
  +
| rowspan=5 | [[Acyclovir]] IV
  +
| [[HSV]] and [[VZV]]
  +
| 1-3 month infants
  +
|
  +
| 20 mg/kg/dose q8h
  +
|-
  +
| rowspan=2 | [[HSV]] encephalitis
  +
| 3 months to 12 years
  +
|
  +
| 10-15 mg/kg/dose q8h
  +
|-
  +
| >12 years
  +
|
  +
| 10 mg/kg/dose q8h
  +
|-
  +
| [[HSV]] (severe or immunocompromised)
  +
|
  +
|
  +
| 5-10 mg/kg/dose q8h
  +
|-
  +
| [[VZV]] (severe or immunocompromised)
  +
|
  +
|
  +
| 10 mg/kg/dose q8h
  +
|-
  +
| rowspan=4 | [[Acyclovir]] PO
  +
| [[HSV]] (mild-moderate and immunocompetent)
  +
|
  +
|
  +
| 30-50 mg/kg/day split 3-5 times daily
  +
|-
  +
| [[HSV]] (severe or immunocompromised, step-down)
  +
|
  +
|
  +
| 60-80 mg/kg/day split 3-5 times daily
  +
|-
  +
| [[VZV]] (immunocompetent)
  +
|
  +
|
  +
| 80 mg/kg/day split 3-5 times daily
  +
|-
  +
| [[VZV]] (severe or immunocompromised, step-down)
  +
|
  +
|
  +
| 80 mg/kg/day split 3-5 times daily
  +
|-
  +
| rowspan=10 | [[Valacyclovir]] PO
  +
| rowspan=5 | [[HSV]] cold sores
  +
| 3 months to 11 years
  +
| 6 to <15 kg
  +
| 250 mg bid x3 days
  +
|-
  +
| 3 months to 11 years
  +
| 15 to <30 kg
  +
| 500 mg bid x3 days
  +
|-
  +
| 3 months to 11 years
  +
| 30 to 36 kg
  +
| 750 mg bid x3 days
  +
|-
  +
| 3 months to 11 years
  +
| >36 kg
  +
| 1 g bid x3 days
  +
|-
  +
| ≥12 years
  +
|
  +
| 2 g bid x1 day
  +
|-
  +
| rowspan=5 | [[VZV]]
  +
| rowspan=5 | ≥2 years
  +
| any
  +
| 20 mg/kg tid
  +
|-
  +
| 6 to <15 kg
  +
| 250 mg tid x5 days
  +
|-
  +
| 15 to <30 kg
  +
| 500 mg tid x5 days
  +
|-
  +
| 30 to 36 kg
  +
| 750 mg tid x5 days
  +
|-
  +
| >36 kg
  +
| 1 g tid x5 days
  +
|-
  +
| rowspan=19 | [[Oseltamivir]] PO
  +
| rowspan=19 | [[influenza]]
  +
| rowspan=8 | 1 to 8 months (term)
  +
| 3-3.5 kg
  +
| 9 mg bid
  +
|-
  +
| 3.6-4.5 kg
  +
| 12 mg bid
  +
|-
  +
| 4.6-5.5 kg
  +
| 15 mg bid
  +
|-
  +
| 5.6-6.5 kg
  +
| 18 mg bid
  +
|-
  +
| 6.6-7.5 kg
  +
| 21 mg bid
  +
|-
  +
| 7.6-8.5 kg
  +
| 24 mg
  +
|-
  +
| 8.6-9.5 kg
  +
| 27 mg bid
  +
|-
  +
| ≥9.6 kg
  +
| 30 mg bid
  +
|-
  +
| rowspan=7 | 9 to 11 months
  +
| 3-3.5 kg
  +
| 12 mg bid
  +
|-
  +
| 3.6-4.5 kg
  +
| 15 mg bid
  +
|-
  +
| 4.6-5.5 kg
  +
| 18 mg bid
  +
|-
  +
| 5.6-6.5 kg
  +
| 21 mg bid
  +
|-
  +
| 6.6-7.5 kg
  +
| 24 mg bid
  +
|-
  +
| 7.6-8.5 kg
  +
| 27 mg bid
  +
|-
  +
| ≥8.6 kg
  +
| 30 mg bid
  +
|-
  +
| rowspan=4 | >12 months
  +
| <15 kg
  +
| 30 mg bid
  +
|-
  +
| 15-23 kg
  +
| 45 mg bid
  +
|-
  +
| 23-40 kg
  +
| 60 mg bid
  +
|-
  +
| >40 kg
  +
| 75 mg bid
  +
|}
  +
  +
== Antimalarials ==
  +
  +
{| class="wikitable" style="width:100%"
  +
! Drug
  +
! Indication
  +
! Age and weight
  +
! Dose
  +
|-
  +
| rowspan=2 | [[Artesunate]]
  +
| rowspan=2 | [[malaria]] (treatment)
  +
| &lt;20 kg
  +
| 3 mg/kg/dose at 0, 12, 24, and 48 hours
  +
|-
  +
| &gt;20 kg
  +
| 2.4 mg/kg/dose at 0, 12, 24, and 48 hours
  +
|-
  +
| rowspan=12 | [[Atovaquone-proguanil]] PO
  +
| rowspan=6 | [[malaria]] (treatment)
  +
| 5-8 kg
  +
| 125 mg-50 mg (2 peds tabs) daily x3 days
  +
|-
  +
| 8.01-10 kg
  +
| 187.5 mg-75 mg (3 peds tabs) daily x3 days
  +
|-
  +
| 10.01-20 kg
  +
| 250 mg-100 mg (1 adult tab) daily x3 days
  +
|-
  +
| 20.01-30 kg
  +
| 500 mg-200 mg (2 adult tabs) daily x3 days
  +
|-
  +
| 30.01-40 kg
  +
| 750 mg-300 mg (3 adult tabs) daily x3 days
  +
|-
  +
| &gt;40 kg
  +
| 1000 mg-400 mg (4 adult tabs) daily x3 days
  +
|-
  +
| rowspan=6 | [[malaria]] (prophylaxis)
  +
| 5-8 kg
  +
| 31.25 mg-12.5 mg (1/2 peds tabs) daily
  +
|-
  +
| 8.01-10 kg
  +
| 46.875 mg-18.75 mg (3/4 peds tabs) daily
  +
|-
  +
| 10.01-20 kg
  +
| 62.5 mg-25 mg (1 peds tab) daily
  +
|-
  +
| 20.01-30 kg
  +
| 125 mg-50 mg (2 peds tabs) daily
  +
|-
  +
| 30.01-40 kg
  +
| 187.5 mg-75 mg(3 peds tabs) daily
  +
|-
  +
| &gt;40 kg
  +
| 250 mg-100 mg (1 adult tab) daily
 
|}
 
|}
   

Latest revision as of 10:22, 20 July 2020

Antibiotics

Penicillins

Drug Indication Age and weight Dose
Penicillin G IV/IM moderate to severe infections 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
meningitis 400,000 U/kg/day split q4h (max 24 MU/day)
Penicillin VK PO mild to moderate infections 25-50 mg/kg/day split q8-12h
rheumatic fever (treatment) ≤ 27 kg 300 mg PO bid x10 days
> 27 kg 600 mg PO bid x 10 days
rheumatic fever (prophylaxis) > 5 years 300 mg PO bid
asplenia (prophylaxis) 6 months to 5 years 150 mg PO bid
> 5 years 300 mg PO bid
Cloxacillin IV methicillin-susceptible Staphylococcus aureus 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
Cloxacillin PO use cephalexin instead
Ampicillin IV usual dose neonates 100-200 mg/kg/day split q6-8h
infants and children 100-200 mg/kg/day split q6h (max 2 g/dose)
meningitis neonates 300 mg/kg/day split q6-8h
infants and children 300-400 mg/kg/day split q4-6h (max 2 g/dose)
Amoxicillin PO usual dose 40-50 mg/kg/day split q8h
Streptococcus pneumoniae 80-90 mg/kg/day split q8h
Group A Streptococcus pharyngitis 50 mg/kg once daily x10 days (max 1 g/dose)
Amoxicillin-clavulanic acid PO usual dose 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
Streptococcus pneumoniae 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
Piperacillin-tazobactam IV usual dose 240-300 mg/kg/day (pip component) split q6-8h
Pseudomonas aeruginosa or cystic fibrosis 400 mg/kg/day split q6h

Cephalosporins

Drug Indication Age and weight Dose
First generation
Cefazolin IV/IM usual dose 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
Cephalexin PO usual dose 25-100 mg/kg/day split qid
osteomyelitis (oral step-down) 100-150 mg/kg/day split qid
Second generation
Cefuroxime IV/IM usual dose 100-150 mg/kg/day split q8h (max 2 g/dose)
Cefuroxime azetil PO poor bioavailability; not recommended
Cefprozil PO usual dose 15-30 mg/kg/day split bid (max 1 g/day)
Third generation
Cefotaxime IV/IM usual dose 0-7 days 50 mg/kg/dose q8h
>7 days 50 mg/kg/dose q8h
infants and children 100-200 mg/kg/day split q6-8h (max 6 g/day)
meningitis 0-7 days 50 mg/kg/dose q8h
>7 days 50 mg/kg/dose q6h
infants and children 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
Ceftriaxone IM/IV usual dose >1 month 50-75 mg/kg q24h (max 2 g/day)
meningitis >1 month 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
gonorrhea ≥9 years 250 mg IM once
<9 years 50 mg/kg IM once (max 250 mg)
Ceftazidime IM/IV usual dose 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
meningitis or cystic fibrosis 200 mg/kg/day split q6-8h (max 6 g/day)
Cefixime PO usual dose 8 mg/kg/day split q12-24h (max 400 mg/day)

Carbapenems

Drug Indication Age and weight Dose
Meropenem usual dose 20 mg/kg/dose q8h (max 1 g/dose)
meningitis 40 mg/kg/dose q8h (max 2 g/dose)
Ertapenem usual dose 3 months to 12 years 15 mg/kg/dose q12h (max 500 mg/dose)
≥13 years 1 g daily

Glycopeptides

Drug Indication Age and weight Dose
Vancomycin IV usual dose 40-60 mg/kg/day split q6-12h (max 2+ g/day)
meningitis or MRSA 60 mg/kg/day split q6-8h (max 4 g/day)
Vancomycin PO Clostridium difficile 10 mg/kg/dose q6h (max 125 mg/dose)

Macrolides

Drug Indication Age and weight Dose
Clarithromycin PO usual dose 7.5 mg/kg/dose bid
Azithromycin PO/IV usual dose 10 mg/kg (max 500 mg) once, then 5 mg/kg (max 250 mg) daily for 4 days
pertussis <6 months 10 mg/kg q24h for 5 days
≥6 months 10 mg/kg once (max 500 mg) then 5 mg/kg dailys (max 250 mg)
chlamydia <9 years 20 mg/kg (max 1 g) once
≥9 years 1 g once
chlamydial conjunctivitis infants 20 mg/kg once daily for 3 days

Aminoglycosides

Drug Indication Age and weight Dose
Tobramycin IV usual dose 5-7 mg/kg/dose q24h
cystic fibrosis 10-12 mg/kg/dose q24h
Tobramycin INH cystic fibrosis 80 mg bid to tid
Gentamicin IV usual dose ≤7 days 4 mg/kg/dose q24h
>7 days 5 mg/kg/dose q24h
infants and children 5-7 mg/kg/dose q24h
synergy for Gram-positive infections 1 mg/kg/dose q8h
  • Extended-frequency dosing of aminoglycosides is preferred for all patients older than 1 month with the exception of endocarditis or extensive burns
  • Monitor trough levels pre-second dose, with target of <1 mg/L

Fluoroquinolones

Drug Indication Age and weight Dose
Ciprofloxacin IV/PO usual dose 20-30 mg/kg/day split q12h (max 400 mg/dose IV or 750 mg/dose PO)
Levofloxacin PO/IV usual dose ≤5 years 10 mg/kg q12h
>5 years 10 mg/kg daily (max 750 mg/day)

Miscellaneous

Drug Indication Age and weight Dose
Lincosamides
Clindamycin IV usual dose 20-40 mg/kg/day split q6h (max 600 mg/dose)
toxic shock syndrome or necrotizing fasciitis 600-900 mg q8h
Clindamycin PO usual dose 10-30 mg/kg/day split q6-8h
Nitroimidazole
Metronidazole PO/IV anaerobic infections 20-30 mg/kg/day split q8-12h (max 1500 mg/day IV or 2000 mg/day PO)
severe infections 50 mg/kg/day split q8h
C. difficile infection 30 mg/kg/day split q6-8h (max 1500 mg/day)
Sulfonamides
Co-trimoxazole PO/IV usual dose 8-10 mg/kg/day TMP split q12h
MRSA 8-12 mg/kg/day TMP split q12h
Pneumocystis pneumonia (treatment) 15-20 mg/kg/day TMP split q6-8h
Pneumocystis pneumonia (prophylaxis) 3-5 mg/kg/day TMP split q12h on Mon-Wed-Fri
Trimethoprim PO UTI (prophylaxis) 2-3 mg/kg/day split q12h
Others
Nitrofurantoin PO UTI (treatment) 5-7 mg/kg/day split q6h (max 400 mg/day)
UTI (prophylaxis) 1-2 mg/kg/day daily
Macrobid PO UTI (treatment) >12 years 100 mg bid

Antifungals

Drug Indication Age and weight Dose
Liposomal amphotericin B IV usual dose 3-5 mg/kg daily
severe infections 10 mg/kg daily
Caspofungin IV usual dose 70 mg/m2 once (max 70 mg) followed by 50 mg/m2 daily (max 50 mg)
Nystatin PO oral candidiasis infants 100,000 U swish & swallow qid
children 250,000 U swish & swallow qid
adolescents 500,000 U swish & swallow qid

Antivirals

Drug Indication Age Weight Dose
Acyclovir IV HSV and VZV 1-3 month infants 20 mg/kg/dose q8h
HSV encephalitis 3 months to 12 years 10-15 mg/kg/dose q8h
>12 years 10 mg/kg/dose q8h
HSV (severe or immunocompromised) 5-10 mg/kg/dose q8h
VZV (severe or immunocompromised) 10 mg/kg/dose q8h
Acyclovir PO HSV (mild-moderate and immunocompetent) 30-50 mg/kg/day split 3-5 times daily
HSV (severe or immunocompromised, step-down) 60-80 mg/kg/day split 3-5 times daily
VZV (immunocompetent) 80 mg/kg/day split 3-5 times daily
VZV (severe or immunocompromised, step-down) 80 mg/kg/day split 3-5 times daily
Valacyclovir PO HSV cold sores 3 months to 11 years 6 to <15 kg 250 mg bid x3 days
3 months to 11 years 15 to <30 kg 500 mg bid x3 days
3 months to 11 years 30 to 36 kg 750 mg bid x3 days
3 months to 11 years >36 kg 1 g bid x3 days
≥12 years 2 g bid x1 day
VZV ≥2 years any 20 mg/kg tid
6 to <15 kg 250 mg tid x5 days
15 to <30 kg 500 mg tid x5 days
30 to 36 kg 750 mg tid x5 days
>36 kg 1 g tid x5 days
Oseltamivir PO influenza 1 to 8 months (term) 3-3.5 kg 9 mg bid
3.6-4.5 kg 12 mg bid
4.6-5.5 kg 15 mg bid
5.6-6.5 kg 18 mg bid
6.6-7.5 kg 21 mg bid
7.6-8.5 kg 24 mg
8.6-9.5 kg 27 mg bid
≥9.6 kg 30 mg bid
9 to 11 months 3-3.5 kg 12 mg bid
3.6-4.5 kg 15 mg bid
4.6-5.5 kg 18 mg bid
5.6-6.5 kg 21 mg bid
6.6-7.5 kg 24 mg bid
7.6-8.5 kg 27 mg bid
≥8.6 kg 30 mg bid
>12 months <15 kg 30 mg bid
15-23 kg 45 mg bid
23-40 kg 60 mg bid
>40 kg 75 mg bid

Antimalarials

Drug Indication Age and weight Dose
Artesunate malaria (treatment) <20 kg 3 mg/kg/dose at 0, 12, 24, and 48 hours
>20 kg 2.4 mg/kg/dose at 0, 12, 24, and 48 hours
Atovaquone-proguanil PO malaria (treatment) 5-8 kg 125 mg-50 mg (2 peds tabs) daily x3 days
8.01-10 kg 187.5 mg-75 mg (3 peds tabs) daily x3 days
10.01-20 kg 250 mg-100 mg (1 adult tab) daily x3 days
20.01-30 kg 500 mg-200 mg (2 adult tabs) daily x3 days
30.01-40 kg 750 mg-300 mg (3 adult tabs) daily x3 days
>40 kg 1000 mg-400 mg (4 adult tabs) daily x3 days
malaria (prophylaxis) 5-8 kg 31.25 mg-12.5 mg (1/2 peds tabs) daily
8.01-10 kg 46.875 mg-18.75 mg (3/4 peds tabs) daily
10.01-20 kg 62.5 mg-25 mg (1 peds tab) daily
20.01-30 kg 125 mg-50 mg (2 peds tabs) daily
30.01-40 kg 187.5 mg-75 mg(3 peds tabs) daily
>40 kg 250 mg-100 mg (1 adult tab) daily